Upstream Bio UPB
NASDAQ UPB
$5.29 +0.10 (+1.93%)
As of: Sep 30, 2026 · 3:55 PM EDT

Upstream Bio (UPB) Capital Expenditures (2024 - 2025)

Updated

Upstream Bio's Capital Expenditures came in at $54,000 for Q4 2025, down 70.8% from $185,000 a year earlier and down 15.6% from the prior quarter.

Analysis

Upstream Bio (UPB) Capital Expenditures (2024 - 2025) Analysis & Trends

For FY2025, Upstream Bio's Capital Expenditures was $165,000, down 67.7% from FY2024.

  • Going back by year, Capital Expenditures was $511,000 in FY2024 (+254.9%) and $144,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Upstream Bio 284.26 Mn 284.26 Mn -3.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 54,000.00
Sep 30, 2025 64,000.00
Dec 31, 2024 185,000.00
API Access

Upstream Bio Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=UPB&period=max&api_key=YOUR_API_KEY